Introduction
ImmunoIVD and its French distributor, AdGeniX, had the pleasure of training a team at CHU Grenoble Alpes in the use of SPOT-it™ assay for severe combined immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA) newborn screening.
The laboratory is now ready to accommodate other French laboratories wishing to gain hands-on experience with the SPOT-it™ Screening Kit.
Contact [email protected] or [email protected], if you are interested to visit the lab or hear more about the SPOT-it™ Screening Kit.
About ImmunoIVD:
Sweden-based ImmunoIVD AB is dedicated to providing reliable, accessible and innovative assays for newborn screening for SCID, SMA and XLA. Our CE IVD marked SPOT-it™ Screening Kits have been used across Europe since 2018.
The assays are highly regarded for their reliability and easy-to-use workflow, requiring minimal laboratory space and equipment investment. We are recognized for our transparent communication and efficient support.